Industry's finest gather for MM&M Awards judgment day

Share this article:
We are a step closer to knowing the finalists of the MM&M Awards 2007 this morning after 48 of the industry’s finest leaders and thinkers spent an entire day yesterday reviewing and scoring the 700-plus submissions.
Top marketing executives from Merck, Novartis, AstraZeneca, GlaxoSmithKline, Schering-Plough and Wyeth joined leaders from Google, Deutsch, McCann, Publicis, GSW Worldwide, CommonHealth and numerous other agencies and publishers in keen debate of an extremely high quality field of entries.
The judges, like everybody else, will not know the results of their efforts until the shortlist of finalists is published in MM&M News Brief on Aug. 14 (and also in the September issue of MM&M); and the individual winners are revealed for the first time at the spectacular awards ceremony and dinner in New York on Nov. 1.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in News

Five things for pharma marketers to know: Tuesday, September 2

Five things for pharma marketers to know: Tuesday, ...

Sanofi and Regeneron unveil Phase-III results of their PCSK9; Merck will present data on its anti-PD-1 at the end of this month; WSJ op/ed suggests US should lead fight against ...

Five things for Pharma Marketers to know: Friday, August 29

Five things for Pharma Marketers to know: Friday, ...

Takeda closes out a good-news, bad-news kind of week, AstraZeneca adds a new clinical trial for its experimental PD-1, and researchers link a funeral to the Ebola outbreak.

Amgen sends PCSK9 to FDA

Amgen sends PCSK9 to FDA

Evolocumab holds the FDA's first filed biologics license application for the class.